R&D Systems™ Recombinant Human CXCL2/GRO beta Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 276GB010/CF

Catalog No. 276GB010CF

Description

The Recombinant Human CXCL2/GRO beta Protein is derived from E. coli. The Recombinant Human CXCL2/GRO beta Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Molecular Weight (g/mol): 8 kDa
• Quantity: 10μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Recombinant: Recombinant

• Gene ID (Entrez): 2920
• Name: CXCL2/GRO beta/MIP-2/CINC-3 aa 35-107
• Source: E. coli-derived human CXCL2/GRO beta/MIP-2/CINC-3 protein Ala35-Asn107
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.